MicroRNA 196B Regulates HOXA5, HOXB6 and GLTP Expression Levels in Colorectal Cancer Cells

被引:16
|
作者
Mo, Ji-Su [1 ,2 ]
Park, Young-Ran [1 ]
Chae, Soo-Cheon [1 ,2 ]
机构
[1] Wonkwang Univ, Sch Med, Dept Pathol, Iksan 54538, Chonbuk, South Korea
[2] Wonkwang Univ, Digest Dis Res Inst, Iksan 54538, Chonbuk, South Korea
关键词
MicroRNA; MIR196B; HOXA5; GLTP; Colorectal cancer; BREAST; GENE; LUNG; APOPTOSIS;
D O I
10.1007/s12253-018-0399-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MiRNAs are non-coding RNAs that play important roles in the pathogenesis of human diseases by regulating target gene expression in specific cells or tissues. Previously we identified colorectal cancer (CRC) associated MIR196B, which was specifically up-regulated in CRC cells and tissue. We also identified 18 putative MIR196B target genes by comparing the mRNAs down-regulated in MIR196B-overexpressed cells with MIR196B target genes predicted by public bioinformatics tools. In this study, we verified the association between MIR196B and three genes, HOXA5, HOXB6 and GLTP. HOXA5, HOXB6 and GLTP transcripts were directly down-regulated by MIR196B. The mRNA and proteins levels of HOXA5, HOXB6 and GLTP were also down-regulated in CRC cells by the up-regulated MIR196B. GLTP protein expression was decreased in CRC tissues compared to adjacent non-tumor tissues. These results suggest that HOXA5, HOXB6, and GLTP were direct target genes of MIR196B in CRC cells, and that the up-regulated MIR196B in CRC tissue regulates the expression levels of HOXA5, HOXB6, and GLTP during colorectal carcinogenesis.
引用
收藏
页码:953 / 959
页数:7
相关论文
共 50 条
  • [1] MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells
    Mo, Ji-Su
    Alam, Khondoker Jahengir
    Kang, In-Hong
    Park, Won Cheol
    Seo, Geom-Seog
    Choi, Suck-Chei
    Kim, Hun-Soo
    Moon, Hyung-Bae
    Yun, Ki-Jung
    Chae, Soo-Cheon
    ONCOTARGET, 2015, 6 (05) : 2843 - 2855
  • [2] The significance of HOXA5 expression in colorectal cancer
    Chinen, Yoshinao
    Hata, Tsuyoshi
    Sekido, Yuki
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Takahashi, Hidekazu
    Uemura, Mamoru
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Eguchi, Hidetoshi
    CANCER SCIENCE, 2022, 113 : 1131 - 1131
  • [3] Unique spatial and cellular expression patterns of Hoxa5, Hoxb4, and Hoxb6 proteins in normal developing murine lung are modified in pulmonary hypoplasia
    Volpe, MaryAnn Vitoria
    Wang, Karen Ting Wai
    Nielsen, Heber Carl
    Chinoy, Mala Romeshchandra
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2008, 82 (08) : 571 - 584
  • [4] MicroRNA 196b regulates radioresistance of gastric cancer cells by targeting HR23B
    Kim, S.
    Shen, Y. N.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S102 - S102
  • [5] HOXA5 regulates hMLH1 expression in breast cancer cells
    Duriseti, Sai
    Winnard, Paul T., Jr.
    Mironchik, Yelena
    Vesuna, Farhad
    Raman, Ana
    Raman, Venu
    NEOPLASIA, 2006, 8 (04): : 250 - 258
  • [6] HOXA5 inhibits tumor growth of gastric cancer under the regulation of microRNA-196a
    Wu, Yingxin
    Zhou, Tong
    Tang, Qian
    Xiao, Jiangwei
    GENE, 2019, 681 : 62 - 68
  • [7] microRNA-196b regulates HOXB7 in cervical cancer
    How, Christine
    Hui, Angela
    Boutros, Paul
    Clarke, Blaise
    Pintilie, Melania
    Fyles, Anthony
    Liu, Fei-Fei
    CANCER RESEARCH, 2012, 72
  • [8] The role of microRNA-130a in regulating HOXA5 expression in breast cancer progression
    Banda, Malathi
    Speyer, Cecilia L.
    Gorski, David H.
    CANCER RESEARCH, 2011, 71
  • [9] Stemming Colorectal Cancer Growth and Metastasis: HOXA5 Forces Cancer Stem Cells to Differentiate
    Tan, Si Hui
    Barker, Nick
    CANCER CELL, 2015, 28 (06) : 683 - 685
  • [10] Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer
    Li, Daojiang
    Bai, Yang
    Feng, Zhicai
    Li, Wanwan
    Yang, Chunxing
    Guo, Yihang
    Lin, Changwei
    Zhang, Yi
    He, Quanyong
    Hu, Gui
    Li, Xiaorong
    FRONTIERS IN ONCOLOGY, 2019, 9